165 related articles for article (PubMed ID: 36262801)
1. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
Krausz M; Uhlmann A; Rump IC; Ihorst G; Goldacker S; Sogkas G; Posadas-Cantera S; Schmidt R; Feißt M; Alsina L; Dybedal I; Recher M; Warnatz K; Grimbacher B
Contemp Clin Trials Commun; 2022 Dec; 30():101008. PubMed ID: 36262801
[TBL] [Abstract][Full Text] [Related]
2. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.
Taghizade N; Babayeva R; Kara A; Karakus IS; Catak MC; Bulutoglu A; Haskologlu ZS; Akay Haci I; Tunakan Dalgic C; Karabiber E; Bilgic Eltan S; Yorgun Altunbas M; Sefer AP; Sezer A; Kokcu Karadag SI; Arik E; Karali Z; Ozhan Kont A; Tuzer C; Karaman S; Mersin SS; Kasap N; Celik E; Kocacik Uygun DF; Aydemir S; Kiykim A; Aydogmus C; Ozek Yucel E; Celmeli F; Karatay E; Bozkurtlar E; Demir S; Metin A; Karaca NE; Kutukculer N; Aksu G; Guner SN; Keles S; Reisli I; Kendir Demirkol Y; Arikoglu T; Gulez N; Genel F; Kilic SS; Aytekin C; Keskin O; Yildiran A; Ozcan D; Altintas DU; Ardeniz FO; Dogu EF; Ikinciogullari KA; Karakoc-Aydiner E; Ozen A; Baris S
J Allergy Clin Immunol; 2023 Dec; 152(6):1634-1645. PubMed ID: 37595759
[TBL] [Abstract][Full Text] [Related]
4. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
[TBL] [Abstract][Full Text] [Related]
5. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
6. Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.
Gámez-Díaz L; Seidel MG
Front Pediatr; 2021; 9():662645. PubMed ID: 33996698
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.
Frye BC; Rump IC; Uhlmann A; Schubach F; Ihorst G; Grimbacher B; Zissel G; Quernheim JM
Contemp Clin Trials Commun; 2020 Sep; 19():100575. PubMed ID: 32551397
[TBL] [Abstract][Full Text] [Related]
8. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.
Kiykim A; Ogulur I; Dursun E; Charbonnier LM; Nain E; Cekic S; Dogruel D; Karaca NE; Cogurlu MT; Bilir OA; Cansever M; Kapakli H; Baser D; Kasap N; Kutlug S; Altintas DU; Al-Shaibi A; Agrebi N; Kara M; Guven A; Somer A; Aydogmus C; Ayaz NA; Metin A; Aydogan M; Uncuoglu A; Patiroglu T; Yildiran A; Guner SN; Keles S; Reisli I; Aksu G; Kutukculer N; Kilic SS; Yilmaz M; Karakoc-Aydiner E; Lo B; Ozen A; Chatila TA; Baris S
J Allergy Clin Immunol Pract; 2019; 7(8):2790-2800.e15. PubMed ID: 31238161
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
10. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
Krone KA; Winant AJ; Vargas SO; Platt CD; Bartnikas LM; Janssen E; Lillehei C; Lee EY; Fishman MP; Casey A
Pediatr Pulmonol; 2021 Jul; 56(7):2232-2241. PubMed ID: 33710794
[TBL] [Abstract][Full Text] [Related]
12. Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.
Shamriz O; Shadur B; NaserEddin A; Zaidman I; Simanovsky N; Elpeleg O; Kerem E; Reiter J; Stepensky P
Eur J Pediatr; 2018 Aug; 177(8):1163-1172. PubMed ID: 29777306
[TBL] [Abstract][Full Text] [Related]
13. Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
Alroqi FJ; Charbonnier LM; Baris S; Kiykim A; Chou J; Platt CD; Algassim A; Keles S; Al Saud BK; Alkuraya FS; Jordan M; Geha RS; Chatila TA
J Allergy Clin Immunol; 2018 Mar; 141(3):1050-1059.e10. PubMed ID: 28601686
[TBL] [Abstract][Full Text] [Related]
14. LRBA deficiency: a rare cause of type 1 diabetes, colitis, and severe immunodeficiency.
Kardelen AD; Kara M; Güller D; Ozturan EK; Abalı ZY; Ceylaner S; Kıykım A; Cantez S; Torun SH; Poyrazoglu S; Bas F; Darendelıler F
Hormones (Athens); 2021 Jun; 20(2):389-394. PubMed ID: 33155142
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review.
Jamee M; Hosseinzadeh S; Sharifinejad N; Zaki-Dizaji M; Matloubi M; Hasani M; Baris S; Alsabbagh M; Lo B; Azizi G
Clin Exp Immunol; 2021 Jul; 205(1):28-43. PubMed ID: 33788257
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in
Musabak U; Erdoğan T; Ceylaner S; Özbek E; Suna N; Özdemir BH
World J Clin Cases; 2023 Sep; 11(26):6176-6182. PubMed ID: 37731560
[TBL] [Abstract][Full Text] [Related]
17. Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency.
Yang L; Xue X; Chen X; Wu J; Yang X; Xu L; Tang X; Wang M; Mao H; Zhao X
Genes Dis; 2021 Sep; 8(5):662-668. PubMed ID: 34291137
[TBL] [Abstract][Full Text] [Related]
18. Interstitial Lung Disease in an Adolescent Girl with Lipopolysaccharide-Responsive Beige-Like Anchor Deficiency.
Tuğcu GD; Eryılmaz Polat S; Metin A; Orhan D; Cinel G
Pediatr Allergy Immunol Pulmonol; 2022 Sep; 35(3):133-138. PubMed ID: 36121783
[No Abstract] [Full Text] [Related]
19. Therapeutic options for CTLA-4 insufficiency.
Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
[TBL] [Abstract][Full Text] [Related]
20. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]